📷 Image: Wikimedia Commons / Hayes, Richard, accomptant and writing-master
Business
Angel One Targets 39% Upside in Gujarat Pharma Stock for Long-Term Hold
✍️ livemint.com
🗓 19 Aug 2026, 05:04 PM
👁 11
Angel One has flagged a Gujarat-based pharmaceutical company as a long‑term buy, projecting a 39% upside on its shares.
Angel One’s research team has identified a Gujarat‑based pharmaceutical company as a promising long‑term investment.
The brokerage expects a 39% upside based on valuation multiples, robust growth prospects, and favorable industry dynamics.
This recommendation aligns with Angel One’s broader strategy to spot undervalued pharma stocks that can deliver sustainable returns.
Investors are advised to weigh the upside potential against market volatility and the company’s fundamentals before making a decision.
The brokerage expects a 39% upside based on valuation multiples, robust growth prospects, and favorable industry dynamics.
This recommendation aligns with Angel One’s broader strategy to spot undervalued pharma stocks that can deliver sustainable returns.
Investors are advised to weigh the upside potential against market volatility and the company’s fundamentals before making a decision.